Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Physical removal of malignant tissue” refers to surgical interventions designed to treat cancer by excising (cutting out) malignant growths and, often, a margin of healthy tissue around them to minimize the risk of recurrence. This encompasses various procedures—including excision, tumor resection, Mohs surgery, and wide local excision—for many cancer types. The main goal is to achieve complete tumor removal, often followed by analysis of the margins to confirm no residual disease. Physical removal is generally not a drug target, receptor, enzyme, or transporter but rather a primary mode of cancer therapy. This approach is effective for tumors that are localized and accessible; in more advanced cases, surgery may be part of combination therapy, also involving chemotherapy, radiation, or immunotherapy. The appropriateness and risks of surgery depend on tumor location, stage, patient health, and other factors[2][3][4][6][7][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physical removal of malignant tissue.